Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
FTSE 100
8,139.83
+60.97
(+0.75%)
FTSE 250
19,824.16
+222.18
(+1.13%)
AIM
755.28
+2.16
(+0.29%)
GBP/EUR
1.1679
+0.0022
(+0.19%)
GBP/USD
1.2494
-0.0017
(-0.13%)
Bitcoin GBP
51,213.17
+798.43
(+1.58%)
NLS Pharmaceutics Ltd. (NLSP)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.1367
+0.0043
(+3.25%)
At close: 04:00PM EDT
0.1368
+0.00
(+0.07%)
After hours:
04:22PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
Operating expenses
Research development
7,816
8,977
5,919
99.58
Selling general and administrative
6,528
6,506
5,941
2,200
Total operating expenses
14,344
15,482
11,861
2,299
Operating income or loss
-14,344
-15,482
-11,861
-2,299
Interest expense
91.815
100.866
68.134
233.7
Total other income/expenses net
-1,032
-912.45
-17.323
-328.365
Income before tax
-15,468
-16,496
-11,946
-2,861
Income from continuing operations
-15,468
-16,496
-11,946
-2,861
Net income
-15,468
-16,496
-11,946
-2,861
Net income available to common shareholders
-15,468
-16,496
-11,946
-2,861
Basic EPS
-0.50
-0.84
-1.00
-0.27
Diluted EPS
-0.50
-0.84
-1.00
-0.27
Basic average shares
30,824
19,683
11,902
11,779
Diluted average shares
30,824
19,683
11,902
11,779
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.